By pandemic of COVID-19 continues unabated and with millions of cases around the world, everyone is looking forward to vaccine. So far the University of Oxford is the one that has given hope on the subject after having successfully tested several people.
And now the Serum Institute of India, one of the largest vaccine manufacturers in the world, partnered with the University of Oxford to develop the Covid-19 vaccine if approved.
In an exclusive interview on India Today TV, o Adar Poonawalla, CEO of the Serum Institute of India, stated that his company will offer 50% of the manufactured COVID-19 vaccines in India and the rest in other countries.
Mr Poonawalla said his company wanted to carry out phase 3 of the Oxford University vaccine human trials in India. It therefore seeks regulatory approvals from the competent authorities.
"We said we wanted to give half of our production to India and the other half to other countries in equal proportions every month. The government was supportive. We need to understand that this is a global crisis and people around the world need to be protected. "It's important to immunize the whole world," said Poonawalla.
The Government of India intends to distribute the vaccine free of charge
Regarding the cost of the vaccine, Mr Poonawalla said he did not yet know what it would be, as the vaccine was being tested. According to him, the government will buy the vaccine from companies and then distribute it for free as part of a vaccination program. The CEO said that the company does not seek to make a profit in the midst of the pandemic.
He also said that his company will offer the COVID-19 vaccine for $ 2-3 in African countries.